These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12890863)

  • 1. The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis.
    Jaakkola E; Crane AM; Laiho K; Herzberg I; Sims AM; Bradbury L; Calin A; Brophy S; Kauppi M; Kaarela K; Wordsworth BP; Tuomilehto J; Brown MA
    Rheumatology (Oxford); 2004 Jan; 43(1):32-8. PubMed ID: 12890863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.
    van der Paardt M; Crusius JB; García-González MA; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Apr; 64(4):616-9. PubMed ID: 15769917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait.
    Zhang Y; Liao Z; Wei Q; Pan Y; Wang X; Cao S; Guo Z; Wu Y; Rong J; Jin O; Xu M; Lin Z; Gu J
    PLoS One; 2016; 11(12):e0166888. PubMed ID: 27973620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 10 polymorphisms in ankylosing spondylitis.
    Goedecke V; Crane AM; Jaakkola E; Kaluza W; Laiho K; Weeks DE; Wilson J; Kauppi M; Kaarela K; Tuomilehto J; Wordsworth BP; Brown MA
    Genes Immun; 2003 Jan; 4(1):74-6. PubMed ID: 12595905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
    Cascino I; Paladini F; Belfiore F; Cauli A; Angelini C; Fiorillo MT; Mathieu A; Sorrentino R
    Arthritis Rheum; 2007 Aug; 56(8):2640-51. PubMed ID: 17665395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
    Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
    Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis.
    Wei JC; Yen JH; Juo SH; Chen WC; Wang YS; Chiu YC; Hsieh TJ; Guo YC; Huang CH; Wong RH; Wang HP; Tsai KL; Wu YC; Chang HW; Hsi E; Chang WP; Chang WC
    PLoS One; 2011; 6(6):e20426. PubMed ID: 21674042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA genes with ankylosing spondylitis in Han population of eastern China.
    Fang M; Chen R; Cai Q; Duan S; Lv K; Cheng N; Sun S
    Scand J Immunol; 2007 Jun; 65(6):559-66. PubMed ID: 17523949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel gene variation of TNFalpha associated with ankylosing spondylitis: a reconfirmed study.
    Zhu X; Wang Y; Sun L; Song Y; Sun F; Tang L; Huo Z; Li J; Yang Z
    Ann Rheum Dis; 2007 Nov; 66(11):1419-22. PubMed ID: 17472990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.
    Green AJ; Barcellos LF; Rimmler JB; Garcia ME; Caillier S; Lincoln RR; Bucher P; Pericak-Vance MA; Haines JL; Hauser SL; Oksenberg JR;
    J Neuroimmunol; 2001 May; 116(1):116-24. PubMed ID: 11311337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro-inflammatory and anti-inflammatory cytokines profile in ankylosing spondylitis.
    Babaie F; Mohammadi H; Hemmatzadeh M; Ebrazeh M; Torkamandi S; Yousefi M; Hajaliloo M; Rezaiemanesh A; Salimi S; Salimi R; Safarzadeh E; Baradaran B; Babaloo Z
    Immunol Lett; 2020 Jan; 217():31-38. PubMed ID: 31711818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A*2402 and a microsatellite (D6S248) are secondary independent susceptibility markers to ankylosing spondylitis in Basque patients.
    de Juan MD; Reta A; Belzunegui J; Figueroa M; Maruri N; Cuadrado E
    Hum Immunol; 2004 Feb; 65(2):175-80. PubMed ID: 14969772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals.
    Bettencourt BF; Rocha FL; Alves H; Amorim R; Caetano-Lopes J; Vieira-Sousa E; Pimentel-Santos F; Lima M; Porto G; Branco JC; Fonseca JE; Bruges-Armas J
    Rheumatology (Oxford); 2013 Dec; 52(12):2168-76. PubMed ID: 24046467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
    Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population.
    Szczypiorska M; Sánchez A; Bartolomé N; Arteta D; Sanz J; Brito E; Fernández P; Collantes E; Martínez A; Tejedor D; Artieda M; Mulero J
    Rheumatology (Oxford); 2011 Nov; 50(11):1969-75. PubMed ID: 21865284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of ERAP1 gene single nucleotide polymorphism in susceptibility to ankylosing spondylitis in Iranian population.
    Babaie F; Ebrazeh M; Hemmatzadeh M; Sadat Mohammadi F; Gowhari Shabgah A; Hajaliloo M; Ebrahimi AA; Shirafkan N; Azizi G; Mohammadi H; Babaloo Z
    Immunol Lett; 2018 Sep; 201():52-58. PubMed ID: 30412714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of major loci controlling clinical manifestations of ankylosing spondylitis.
    Brown MA; Brophy S; Bradbury L; Hamersma J; Timms A; Laval S; Cardon L; Calin A; Wordsworth BP
    Arthritis Rheum; 2003 Aug; 48(8):2234-9. PubMed ID: 12905477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population.
    Pimentel-Santos FM; Matos M; Ligeiro D; Mourão AF; Ribeiro C; Costa J; Santos H; Barcelos A; Pinto P; Cruz M; Sousa E; Santos RA; Fonseca JE; Trindade H; Guedes-Pinto H; Branco JC;
    Tissue Antigens; 2013 Dec; 82(6):374-9. PubMed ID: 24498993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of IL-23 receptor gene polymorphism in Iranian patients with ankylosing spondylitis.
    Daryabor G; Mahmoudi M; Jamshidi A; Nourijelyani K; Amirzargar A; Ahmadzadeh N; Farhadi E; Nicknam MH
    Eur Cytokine Netw; 2014 Mar; 25(1):24-9. PubMed ID: 24998354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity.
    Jin L; Weisman M; Zhang G; Ward M; Luo J; Bruckel J; Inman R; Khan MA; Schumacher HR; Maksymowych WP; Mahowald M; Martin T; Rosenbaum JT; Yu DT; Stone M; Watson J; Dickman E; Davis J; Reveille JD
    Rheumatology (Oxford); 2005 Jan; 44(1):55-60. PubMed ID: 15546966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.